-
Views
-
Cite
Cite
G Papadopoulos, S Keymel, G P Minol, A Blehm, S Kruger, C Jung, R Westenfeld, A Lichtenberg, M Kelm, T Zeus, V Veulemans, P5453
Increased perinterventional risk for patients with severe aortic stenosis and coexisting pulmonary hypertension treated by transfemoral aortic valve implantation, European Heart Journal, Volume 39, Issue suppl_1, August 2018, ehy566.P5453, https://doi.org/10.1093/eurheartj/ehy566.P5453 - Share Icon Share
Extract
Background: In patients with severe aortic valve stenosis (AS) and increased perioperative risk, transcatheter aortic valve implantation (TAVI) is known to be a favourable treatment. Coexistence of pulmonary hypertension (PH) is associated with a poor outcome in general. It is though not known whether this applies for a pure transfemoral cohort.
Purpose: Evaluation whether TF-TAVI is a safe and effective procedure in patients with severe AS and coexisting PH.
Methods: We performed a single center retrospective analysis in 606 patients with severe AS with or without coexisting PH. PH was defined as the middle pulmonary arterial pressure ≥25mmHgmeasured in the pre-interventional right heart catheterisation (RHC). 103 patients with inadequate RHC data and 17 patients with missing 30-day-mortality data were excluded from the study. The remaining 486 patients were divided in two groups based on existence (AS+PH: n=311) or absence (AS-PH: n=175) of PH. 30-day mortality, length of stay, complications and short-term outcome were analyzed according to Valve Academic Research Consortium-2 (VARC II) criteria.